DERIVO: Post Market Clinical Follow-Up Study of the Derivo® Embolisation Device
Projektleiter:
Finanzierung:
Industrie;
Primary objective:
Quantitative assessment of morbidity and mortality in patients with intracranial
aneurysms 18 months after flow-diverter treatment with the Derivo®
Embolisation Device
Secondary objective:
- Technical success rate
- Complication rate of aneurysm treatment with the Derivo® flow-diverter
- Initial clinical and angiographic outcome as well as mid-term and longterm
angiographic follow-up results
- Assessment of quality of life
Quantitative assessment of morbidity and mortality in patients with intracranial
aneurysms 18 months after flow-diverter treatment with the Derivo®
Embolisation Device
Secondary objective:
- Technical success rate
- Complication rate of aneurysm treatment with the Derivo® flow-diverter
- Initial clinical and angiographic outcome as well as mid-term and longterm
angiographic follow-up results
- Assessment of quality of life
Kontakt
Dr. Oliver Beuing
Otto-von-Guericke-Universität Magdeburg
Universitätsklinik für Neuroradiologie
Leipziger Str. 44
39120
Magdeburg
Tel.:+49 391 6721681
weitere Projekte
Die Daten werden geladen ...